Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Protein targets for anticancer gold compounds: mechanistic inferencesChiara Gabbiani, Luigi Messori
Anti-Cancer Agents in Medicinal Chemistry|April 13, 2010
Proteomic and metallomic strategies for understanding the mode of action of anticancer metallodrugsChiara Gabbiani, Francesca Magherini, Alessandra Modesti, et al.
Chemical Communications (Cambridge, England)|August 24, 2010
Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysisAlessandro Pratesi, Chiara Gabbiani, Mauro Ginanneschi, et al.
Drug Discovery Today|October 27, 2010
Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectivesMaribel Navarro, Chiara Gabbiani, Luigi Messori, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Promising in Vitro anti-Alzheimer Properties for a Ruthenium(III) ComplexLuigi Messori, Michela Camarri, Teresa Ferraro, et al.
Journal of Inorganic Biochemistry|November 27, 2009
Trans-cis-cis-[RuCl2(DMSO)2(2-amino-5-methyl-thiazole)2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin BPasquale Mura, Mercedes Camalli, Angela Casini, et al.
Biophysical Chemistry|March 14, 2007
DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery studied by circular dichroism and other biophysical techniquesLaura Ciani, Angela Casini, Chiara Gabbiani, et al.
The International Journal of Biochemistry & Cell Biology|March 8, 2011
Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicitySilvia Bolognin, Luigi Messori, Denise Drago, et al.
Pageof 27